TABLE 2.
Clinical outcomes of COVID‐19 patients with and without elevated AST at blood withdrawal after the first positive SARS‐CoV‐2 PCR
| Follow‐up and clinical outcomes | AST ≤ULN(n = 349) | AST > ULN(n = 194) | p‐value |
|---|---|---|---|
| Hospital admission, n (%) | 258 (73.9%) | 176 (90.7%) | <.001 |
| Median hospital stay, days (IQR) | 22.0 (41.0) | 32.0 (36.0) | .261 |
| ICU admission, n (%) | 97 (27.8%) | 99 (51.0%) | <.001 |
| Median ICU stay, days (IQR) | 24.5 (38.0) | 32.0 (29.0) | .775 |
| Intubation, n (%) | 76 (21.8%) | 84 (43.3%) | <.001 |
| Median duration of intubation, days (IQR) | 26.0 (34.0) | 27.0 (28.0) | .981 |
| Death, n (%) | 74 (21.2%) | 62 (32.0%) | .006 |
| COVID‐19‐related death, n (%) | 57 (16.3%) | 56 (28.9%) | .001 |
| Liver‐related death, n (%) | 8 (2.3%) | 16 (8.2%) | .001 |
p‐values depicting statistically significant differences are presented as bold values.